UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission File Number: 001- 39925
TIAN RUIXIANG Holdings Ltd
2107, Block B, Shoudong International
Dongcheng District, Beijing
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x Form 40-F ¨
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release dated March 4, 2026 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
TIAN RUIXIANG Holdings Ltd |
| |
|
|
| Date: March 4,
2026 |
By: |
/s/ Baohai Xu |
| |
Name: |
Baohai Xu |
| |
Title: |
Chief Executive Officer |
Exhibit 99.1
TIAN RUIXIANG Holdings Ltd. Announces
Receipt of Nasdaq Suspension and Delisting Notification
BEIJING, Mar 4, 2026 /PRNewswire/ -- TIAN RUIXIANG
Holdings Ltd. (Nasdaq: TIRX) (the “Company” or “TRX”) today announced that it received notification from Nasdaq
Staff which determined that as of February 27, 2026, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive
trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low
Priced Stocks Rule”) and this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq
Stock Market.
Pursuant to Listing Rule 5815(a)(1)(B)(ii)(e),
the Company’s securities will be delisted from the Capital Market. In that regard, trading of the Company’s shares will be
suspended at the opening of business on March 5, 2026, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the
“SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market.
The Nasdaq Hearings Panel (the “Panel”)
will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market. The Company
is able to present its views with respect to this additional deficiency to the Panel in writing no later than March 10, 2026.
The Company is currently working together with
its advisors to appeal for a stay of the suspension of trading of its securities on Nasdaq or reinstate such trading as soon as possible.
The Company will submit its response to Nasdaq prior to the March 10, 2026 deadline. There is no guarantee that the Company will be able
to stay such suspension or reinstate such trading, or that the Company’s shares will remain listed on Nasdaq. The Company is presently
in the process of implementing the 1-for-50 reverse stock split (the “Reverse Split”) of its ordinary shares.
About TIAN RUIXIANG Holdings Ltd
TIAN RUIXIANG Holdings Ltd, headquartered in Beijing,
China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance
products, which are categorized into two major groups: (1) property and casualty insurance, such as commercial property insurance, liability
insurance, accidental insurance, and automobile insurance; and (2) other types of insurance, such as health insurance, life insurance,
and other miscellaneous insurance.
Forward-Looking Statements
Certain statements in this announcement are forward-looking
statements. These include statements regarding future plans, objectives, expectations and intentions, and involve known and unknown risks
and uncertainties. Words such as “may,” “will,” “expect,” “anticipate,” “aim,”
“estimate,” “intend,” “plan,” “believe,” “continue,” or similar expressions
identify these statements. These forward-looking statements are based on current expectations and assumptions and are not guarantees of
future performance; actual results may differ materially. TIAN RUIXIANG Holdings Ltd. undertakes no obligation to update these statements
for subsequent events or circumstances, except as required by law.
For investor
and media enquiries, please contact:
TIAN RUIXIANG Holdings Ltd
Investor Relations Department
Email: ir@tianrx.com